PACB
Pacific Biosciences of California
NASDAQ: PACB · HEALTHCARE · MEDICAL DEVICES
$1.59
+8.16% today
Updated 2026-04-30
Market cap
$493.67M
P/E ratio
—
P/S ratio
3.09x
EPS (TTM)
$-1.82
Dividend yield
—
52W range
$1 – $3
Volume
5.8M
Pacific Biosciences of California (PACB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.16M | $901000.00 | $135000.00 | $1.67M | $33.86M | $25.98M | $28.18M | $60.59M | $92.78M | $90.71M | $93.47M | $78.63M | $90.89M | $78.89M | $130.51M | $128.30M | $200.52M | $154.01M | $160.00M |
| Revenue growth (YoY) | — | -58.3% | -85.0% | +1140.0% | +1922.9% | -23.3% | +8.5% | +115.0% | +53.1% | -2.2% | +3.0% | -15.9% | +15.6% | -13.2% | +65.4% | -1.7% | +56.3% | -23.2% | +3.9% |
| Cost of revenue | — | $42.72M | $84.10M | $136.75M | $20.83M | $25.04M | $21.76M | $37.19M | $39.33M | $46.55M | $58.81M | $53.53M | $56.31M | $46.33M | $71.65M | $79.27M | $147.74M | $116.73M | $109.33M |
| Gross profit | $2.16M | $901000.00 | $135000.00 | $1.67M | $13.03M | $940000.00 | $6.42M | $23.40M | $53.45M | $44.16M | $34.66M | $25.10M | $34.58M | $32.57M | $58.86M | $49.03M | $52.78M | $37.28M | $50.67M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 38.5% | 3.6% | 22.8% | 38.6% | 57.6% | 48.7% | 37.1% | 31.9% | 38.0% | 41.3% | 45.1% | 38.2% | 26.3% | 24.2% | 31.7% |
| R&D | $19.22M | $38.00M | $75.88M | $111.82M | $76.08M | $47.62M | $45.22M | $48.23M | $60.44M | $67.62M | $65.32M | $62.59M | $59.63M | $64.15M | $112.90M | $193.00M | $187.17M | $134.92M | $97.31M |
| SG&A | — | — | — | $30.09M | $46.71M | $47.66M | $38.74M | $38.03M | $45.19M | $47.79M | $59.12M | $63.49M | $75.49M | $72.80M | $124.12M | $160.85M | $168.82M | $175.02M | $141.49M |
| Operating income | $-23.39M | $-44.81M | $-88.07M | $-140.23M | $-109.76M | $-94.34M | $-77.54M | $-62.85M | $-29.13M | $-71.24M | $-89.78M | $-100.99M | $-100.55M | $-104.39M | $-210.44M | $-307.20M | $-334.47M | $-474.31M | $-557.56M |
| Operating margin | -1081.4% | -4973.3% | -65237.0% | -8377.2% | -324.1% | -363.1% | -275.2% | -103.7% | -31.4% | -78.5% | -96.1% | -128.4% | -110.6% | -132.3% | -161.2% | -239.4% | -166.8% | -308.0% | -348.5% |
| EBITDA | $-21.81M | $-41.82M | $-83.97M | $-135.01M | $-103.28M | $-87.52M | $-71.17M | $-59.11M | $-25.09M | $-67.27M | $-80.83M | $-92.92M | $-71.58M | $38.97M | $-250.76M | $-282.24M | $-271.13M | $-242.77M | $-34.20M |
| EBITDA margin | -1008.5% | -4641.7% | -62197.0% | -8064.9% | -305.0% | -336.8% | -252.5% | -97.6% | -27.0% | -74.2% | -86.5% | -118.2% | -78.7% | 49.4% | -192.1% | -220.0% | -135.2% | -157.6% | -21.4% |
| EBIT | $-23.39M | $-44.81M | $-88.07M | $-140.17M | $-109.09M | $-94.17M | $-76.81M | $-63.33M | $-28.77M | $-71.14M | $-89.27M | $-100.14M | $-81.52M | $29.67M | $-262.34M | $-299.56M | $-303.82M | $-296.12M | $-539.10M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $287000.00 | $274000.00 | $2.48M | $2.83M | $2.93M | $3.23M | $2.92M | $2.42M | $2.61M | $267000.00 | $12.53M | $14.69M | $14.34M | $13.41M | $6.95M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-21.52M | $-43.75M | $-87.70M | $-140.17M | $-109.39M | $-94.47M | $-79.29M | $-66.16M | $-31.70M | $-74.38M | $-92.19M | $-102.56M | $-84.13M | $29.40M | $-181.22M | $-314.25M | $-306.74M | $-309.85M | $-546.38M |
| Net income growth (YoY) | — | -103.3% | -100.4% | -59.8% | +22.0% | +13.6% | +16.1% | +16.6% | +52.1% | -134.7% | -24.0% | -11.3% | +18.0% | +134.9% | -716.3% | -73.4% | +2.4% | -1.0% | -76.3% |
| Profit margin | -994.8% | -4856.2% | -64965.2% | -8373.1% | -323.0% | -363.6% | -281.4% | -109.2% | -34.2% | -82.0% | -98.6% | -130.4% | -92.6% | 37.3% | -138.9% | -244.9% | -153.0% | -201.2% | -341.5% |